These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18224409)

  • 1. Chromatin regulation by AML1 complex.
    Yoshida H; Kitabayashi I
    Int J Hematol; 2008 Jan; 87(1):19-24. PubMed ID: 18224409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
    Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
    EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription.
    Li XL; Arai Y; Harada H; Shima Y; Yoshida H; Rokudai S; Aikawa Y; Kimura A; Kitabayashi I
    Oncogene; 2007 Nov; 26(51):7231-9. PubMed ID: 17533375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.
    Kitabayashi I; Aikawa Y; Nguyen LA; Yokoyama A; Ohki M
    EMBO J; 2001 Dec; 20(24):7184-96. PubMed ID: 11742995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A distinct epigenetic signature at targets of a leukemia protein.
    Rossetti S; Hoogeveen AT; Liang P; Stanciu C; van der Spek P; Sacchi N
    BMC Genomics; 2007 Feb; 8():38. PubMed ID: 17266773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Runx1/AML1 in normal and abnormal hematopoiesis.
    Yamagata T; Maki K; Mitani K
    Int J Hematol; 2005 Jul; 82(1):1-8. PubMed ID: 16105753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia.
    Saeed S; Logie C; Francoijs KJ; Frigè G; Romanenghi M; Nielsen FG; Raats L; Shahhoseini M; Huynen M; Altucci L; Minucci S; Martens JH; Stunnenberg HG
    Blood; 2012 Oct; 120(15):3058-68. PubMed ID: 22923494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of the AML1 transcription factor in human leukemia.
    Downing JR; Higuchi M; Lenny N; Yeoh AE
    Semin Cell Dev Biol; 2000 Oct; 11(5):347-60. PubMed ID: 11105899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical and functional link of the leukemia-associated factors AML1 and PML.
    Nguyen LA; Pandolfi PP; Aikawa Y; Tagata Y; Ohki M; Kitabayashi I
    Blood; 2005 Jan; 105(1):292-300. PubMed ID: 15331439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AML1 interconnected pathways of leukemogenesis.
    Michaud J; Scott HS; Escher R
    Cancer Invest; 2003; 21(1):105-36. PubMed ID: 12643014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the AML1 transcription factor in leukemogenesis.
    Lorsbach RB; Downing JR
    Int J Hematol; 2001 Oct; 74(3):258-65. PubMed ID: 11721960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation.
    Kitabayashi I; Yokoyama A; Shimizu K; Ohki M
    EMBO J; 1998 Jun; 17(11):2994-3004. PubMed ID: 9606182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis.
    Wee HJ; Voon DC; Bae SC; Ito Y
    Blood; 2008 Nov; 112(9):3777-87. PubMed ID: 18695000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Runx1/AML1 in leukemia: disrupted association with diverse protein partners.
    Perry C; Eldor A; Soreq H
    Leuk Res; 2002 Mar; 26(3):221-8. PubMed ID: 11792409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells.
    Miller JD; Stacy T; Liu PP; Speck NA
    Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of TEL fusion genes in pediatric leukemias.
    Rubnitz JE; Pui CH; Downing JR
    Leukemia; 1999 Jan; 13(1):6-13. PubMed ID: 10049061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.
    Okuda T; van Deursen J; Hiebert SW; Grosveld G; Downing JR
    Cell; 1996 Jan; 84(2):321-30. PubMed ID: 8565077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUV39H1 interacts with AML1 and abrogates AML1 transactivity. AML1 is methylated in vivo.
    Chakraborty S; Sinha KK; Senyuk V; Nucifora G
    Oncogene; 2003 Aug; 22(34):5229-37. PubMed ID: 12917624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AML1/Runx1 as a versatile regulator of hematopoiesis: regulation of its function and a role in adult hematopoiesis.
    Kurokawa M
    Int J Hematol; 2006 Aug; 84(2):136-42. PubMed ID: 16926135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.